EOM 1352: Fri 7 June 2024, 11:36
Media Pack
News

Current Edition

Volume 17 Issue 4
Discovery Park: Wed 13 November 2024, 10:35
ramusmedical
news

Pegfilgrastim Biosimilar Matches Reference Product

Sandoz's biosimilar of Neulasta, or pegfilgrastim, matched the reference product in a clinical trial, according to the company. Researchers found equivalence in pharm...
20 December 2017 news biosimilar | cancer
Continue Reading →
news

Targovax announces that TG02 has passed the initial safety review in the first-in-man clinical trial in colorectal cancer

Targovax ASA (OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, today announces that TG02 has passed the in...
20 December 2017 news clinical trial | immuno-oncology
Continue Reading →
news

CTI Clinical Trial, Consulting Services Announces Acquisition Of Eurotrials

CTI Clinical Trial and Consulting Services announced the acquisition of Eurotrials, a full-service contract research organization, with more than 20 years of experien...
13 December 2017 news acquisition | clinical trial
Continue Reading →
news

CRISPR Therapeutics Announces Planned European Clinical Trial

CRISPR Therapeutics today announced the submission of a Clinical Trial Application (CTA) today for CTX001 in β-thalassemia. CTX001 is an investigational CRISPR gene-e...
13 December 2017 news application | clinical trial
Continue Reading →
news

Bioethics International Releases Second Good Pharma Scorecard

Bioethics International announced the second publication of its Good Pharma Scorecard ("GPS"), an annual index ranking large pharmaceutical companies and new drugs on...
13 December 2017 news clinical trial | ethics
Continue Reading →
news

Sanofi’s Toujeo® met main objective in head-to-head study versus insulin degludec

Sanofi's Toujeo® met the primary study objective in the first large head-to-head clinical trial1, called BRIGHT study, comparing Toujeo with insulin degludec. Sanofi ...
6 December 2017 news BRIGHT study | clinical trial
Continue Reading →
news

CluePoints Responds to Sponsor and CRO Demand with Two New Appointments

CluePoints, a leading provider of Risk-Based Monitoring (RBM) and Data Quality Oversight solutions for clinical trials, has announced two new strategic appointments t...
6 December 2017 news assesment | clinical trial
Continue Reading →
news

Xultophy® reported a better option than basal-bolus insulin therapy to manage type 2 diabetes by participants in the DUAL VII clinical trial

Once-daily Xultophy® (insulin degludec/liraglutide) was a better option to manage diabetes compared to multiple daily injections of insulin (basal-bolus regimen). Thi...
5 December 2017 news clinical trial | diabetes
Continue Reading →
news

Plasticell and Anthony Nolan to partner in clinical trials of ex vivo expanded cord blood stem cells

Plasticell, a developer of innovative stem cell technologies and cell therapies, today announced it will collaborate with Anthony Nolan, a leading research organisati...
5 December 2017 news clinical trial | hematopoietic
Continue Reading →
news

Owlstone Medical’s Breath Biopsy Platform integrated into GSK’s Phase II Respiratory Disease Clinical Trial

Owlstone Medical Ltd, a diagnostics company developing a breathalyzer for disease, today announced that GSK, a world leader in respiratory, will incorporate Owlstone ...
29 November 2017 news biopsy | breathalyzer
Continue Reading →
Catalyst: 12th January 2026
Quotient

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2026, All Rights Reserved – Powered by Teksyte